JPS6365048B2 - - Google Patents
Info
- Publication number
- JPS6365048B2 JPS6365048B2 JP57016331A JP1633182A JPS6365048B2 JP S6365048 B2 JPS6365048 B2 JP S6365048B2 JP 57016331 A JP57016331 A JP 57016331A JP 1633182 A JP1633182 A JP 1633182A JP S6365048 B2 JPS6365048 B2 JP S6365048B2
- Authority
- JP
- Japan
- Prior art keywords
- layer
- molecular weight
- film preparation
- hydroxypropyl cellulose
- release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940079593 drug Drugs 0.000 claims abstract description 54
- 239000003814 drug Substances 0.000 claims abstract description 54
- 238000002360 preparation method Methods 0.000 claims abstract description 41
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims abstract description 35
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims abstract description 35
- 239000004014 plasticizer Substances 0.000 claims abstract description 21
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 14
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 14
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims abstract description 12
- 150000007524 organic acids Chemical class 0.000 claims abstract description 12
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 7
- 238000003860 storage Methods 0.000 claims description 28
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- 150000003180 prostaglandins Chemical class 0.000 claims description 18
- 229940094443 oxytocics prostaglandins Drugs 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 13
- 238000013270 controlled release Methods 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 11
- 238000009472 formulation Methods 0.000 claims description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- KYBOHGVERHWSSV-VNIVIJDLSA-N gemeprost Chemical compound CCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(=O)OC KYBOHGVERHWSSV-VNIVIJDLSA-N 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 238000007796 conventional method Methods 0.000 claims description 6
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 6
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 5
- 235000002906 tartaric acid Nutrition 0.000 claims description 5
- 239000011975 tartaric acid Substances 0.000 claims description 5
- DZUXGQBLFALXCR-UHFFFAOYSA-N (+)-(9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprost-13-en-1-oic acid Natural products CCCCCC(O)C=CC1C(O)CC(O)C1CCCCCCC(O)=O DZUXGQBLFALXCR-UHFFFAOYSA-N 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims 1
- 238000003475 lamination Methods 0.000 claims 1
- 238000003892 spreading Methods 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 abstract description 4
- 230000000717 retained effect Effects 0.000 abstract description 2
- 229940006138 antiglaucoma drug and miotics prostaglandin analogues Drugs 0.000 abstract 2
- 239000010410 layer Substances 0.000 description 70
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 22
- 229920003112 high viscosity grade hydroxypropyl cellulose Polymers 0.000 description 18
- 239000000243 solution Substances 0.000 description 9
- 229920003169 water-soluble polymer Polymers 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000002411 adverse Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000001087 glyceryl triacetate Substances 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- 229920003114 HPC-L Polymers 0.000 description 1
- 229920003115 HPC-SL Polymers 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000037020 contractile activity Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000007922 dissolution test Methods 0.000 description 1
- 238000009820 dry lamination Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229920003117 medium viscosity grade hydroxypropyl cellulose Polymers 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- DVQHRBFGRZHMSR-UHFFFAOYSA-N sodium methyl 2,2-dimethyl-4,6-dioxo-5-(N-prop-2-enoxy-C-propylcarbonimidoyl)cyclohexane-1-carboxylate Chemical compound [Na+].C=CCON=C(CCC)[C-]1C(=O)CC(C)(C)C(C(=O)OC)C1=O DVQHRBFGRZHMSR-UHFFFAOYSA-N 0.000 description 1
- 238000009823 thermal lamination Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 238000009816 wet lamination Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57016331A JPS58134019A (ja) | 1982-02-05 | 1982-02-05 | プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法 |
| DE8383300564T DE3363321D1 (en) | 1982-02-05 | 1983-02-04 | Long-lasting three layered pharmaceutical film preparations |
| EP83300564A EP0086093B1 (en) | 1982-02-05 | 1983-02-04 | Long-lasting three layered pharmaceutical film preparations |
| AT83300564T ATE19589T1 (de) | 1982-02-05 | 1983-02-04 | Pharmazeutische dreilagen-filmpraeparate mit lang anhaltender wirkung. |
| US06/464,174 US4483846A (en) | 1982-02-05 | 1983-02-07 | Long-lasting three-layered pharmaceutical film preparations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57016331A JPS58134019A (ja) | 1982-02-05 | 1982-02-05 | プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58134019A JPS58134019A (ja) | 1983-08-10 |
| JPS6365048B2 true JPS6365048B2 (US06262066-20010717-C00315.png) | 1988-12-14 |
Family
ID=11913452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57016331A Granted JPS58134019A (ja) | 1982-02-05 | 1982-02-05 | プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法 |
Country Status (5)
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
| JPS5770816A (en) * | 1980-10-17 | 1982-05-01 | Ono Pharmaceut Co Ltd | Multilayered film preparation of prostagladin of prolonged action |
| GB2105990B (en) * | 1981-08-27 | 1985-06-19 | Nitto Electric Ind Co | Adhesive skin patches |
| JPS5948409A (ja) * | 1982-09-10 | 1984-03-19 | Teikoku Seiyaku Kk | 矯正的歯牙移動促進剤 |
| USRE33994E (en) * | 1983-08-16 | 1992-07-14 | Burroughs Wellcome Co. | Pharmaceutical delivery system |
| EP0501523B1 (en) * | 1983-11-14 | 1997-04-09 | Columbia Laboratories, Inc. | Bioadhesive compositions |
| US5225196A (en) * | 1983-11-14 | 1993-07-06 | Columbia Laboratories, Inc. | Bioadhesive compositions and methods of treatment therewith |
| US4601893A (en) * | 1984-02-08 | 1986-07-22 | Pfizer Inc. | Laminate device for controlled and prolonged release of substances to an ambient environment and method of use |
| DE10075031I2 (de) * | 1984-08-17 | 2004-07-01 | Wellcome Found | Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs. |
| US4824676A (en) * | 1984-10-11 | 1989-04-25 | Schering Corporation | Physiological means of enhancing transdermal delivery of drugs |
| US5008111A (en) * | 1984-10-11 | 1991-04-16 | Schering Corporation | Physiological means of enhancing transdermal delivery of drugs |
| US4693895A (en) * | 1984-10-26 | 1987-09-15 | Alza Corporation | Colon delivery system |
| US4752478A (en) * | 1984-12-17 | 1988-06-21 | Merck & Co., Inc. | Transdermal system for timolol |
| US4738847A (en) * | 1985-01-14 | 1988-04-19 | Kimberly-Clark Corporation | Multi-ply virucidal product |
| JPS61280423A (ja) * | 1985-06-05 | 1986-12-11 | Kiyuukiyuu Yakuhin Kogyo Kk | 口腔内粘膜貼付剤 |
| US4713244A (en) * | 1985-08-16 | 1987-12-15 | Bausch & Lomb Incorporated | Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent |
| US4668506A (en) * | 1985-08-16 | 1987-05-26 | Bausch & Lomb Incorporated | Sustained-release formulation containing and amino acid polymer |
| JPS62103012A (ja) * | 1985-10-23 | 1987-05-13 | Eisai Co Ltd | 多重顆粒 |
| IT1188212B (it) * | 1985-12-20 | 1988-01-07 | Paolo Colombo | Sistema per il rilascio a velocita' controllata di sostanze attive |
| JPS63503540A (ja) * | 1986-05-29 | 1988-12-22 | フセソユーズヌイ、ナウチノ‐イスレドワーチェルスキー、イ、イスピタテルヌイ、インスチツート、メディツィンスコイ、チェフニキ | 生物分解性ポリマー製の抗腫瘍性フィルム |
| EP0249343B1 (en) * | 1986-06-13 | 1992-01-08 | Alza Corporation | Moisture activation of transdermal drug delivery system |
| GB8616669D0 (en) * | 1986-07-09 | 1986-08-13 | Merk Sharpe & Dohme Ltd | Pharmaceutical compositions |
| DE3630603A1 (de) * | 1986-09-09 | 1988-03-10 | Desitin Arzneimittel Gmbh | Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung |
| US5071656A (en) * | 1987-03-05 | 1991-12-10 | Alza Corporation | Delayed onset transdermal delivery device |
| US5236713A (en) * | 1987-10-21 | 1993-08-17 | Teikoku Seiyaku Kabushiki Kaisha | Preparation for intermittently releasing active agent applicable to oral cavity |
| JP2643222B2 (ja) * | 1988-02-03 | 1997-08-20 | エーザイ株式会社 | 多重層顆粒 |
| US4906475A (en) * | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
| US4877618A (en) * | 1988-03-18 | 1989-10-31 | Reed Jr Fred D | Transdermal drug delivery device |
| US5612059A (en) * | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
| US5876752A (en) * | 1990-08-07 | 1999-03-02 | Pfizer Inc. | Use of interfacially-polymerized membranes in delivery devices |
| AU664504B2 (en) * | 1992-12-11 | 1995-11-16 | Colgate-Palmolive Company, The | Polymeric bio-erodible delivery system for the periodontal pocket |
| US6183778B1 (en) | 1993-09-21 | 2001-02-06 | Jagotec Ag | Pharmaceutical tablet capable of liberating one or more drugs at different release rates |
| DE19954245A1 (de) * | 1999-11-11 | 2001-07-19 | Lohmann Therapie Syst Lts | Mehrschichtige filmförmige Zubereitung aus hydrophilen Polymeren zur schnellen Freisetzung von Wirkstoffen |
| WO2001056544A2 (en) | 2000-02-04 | 2001-08-09 | Depomed, Inc. | Shell-and-core dosage form approaching zero-order drug release |
| GB0102342D0 (en) | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
| BRPI0110321B8 (pt) * | 2001-02-27 | 2021-05-25 | Evonik Roehm Gmbh | revestimento e agente de ligacão para formas farmacêuticas, processo para sua producão, uso dos mesmos e forma farmacêutica |
| US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
| US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
| US20070154527A1 (en) * | 2001-10-12 | 2007-07-05 | Monosoirx, Llc | Topical film compositions for delivery of actives |
| US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
| US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
| US6841574B2 (en) * | 2003-01-03 | 2005-01-11 | Nexmed Holdings, Inc. | Topical stabilized prostaglandin E compound dosage forms |
| DE602004012403T2 (de) | 2003-04-29 | 2009-03-19 | Orexigen Therapeutics, Inc., La Jolla | Zusammensetzungen zur beeinflussung des gewichtsverlusts |
| TW200526274A (en) | 2003-07-21 | 2005-08-16 | Smithkline Beecham Plc | Pharmaceutical formulations |
| GB2421431B (en) * | 2004-12-24 | 2007-10-10 | Aquasol Ltd | Dosing systems |
| US7744556B2 (en) | 2005-03-25 | 2010-06-29 | Kimberly-Clark Worldwide, Inc. | Delivery tube assembly for an applicator |
| US7527614B2 (en) | 2005-03-25 | 2009-05-05 | Kimberly-Clark Worldwide, Inc. | Protective tube for a medicated tampon |
| US7919453B2 (en) | 2005-03-25 | 2011-04-05 | Kimberly-Clark Worldwide, Inc. | Dosage cap assembly for an applicator |
| US7993667B2 (en) | 2005-03-25 | 2011-08-09 | Kimberly-Clark Worldwide, Inc. | Methods of manufacturing a medicated tampon assembly |
| US20090074844A1 (en) | 2005-04-28 | 2009-03-19 | Ono Pharmaceutical Co., Ltd. | Trenadermal absorption preparation |
| US7708726B2 (en) | 2005-04-28 | 2010-05-04 | Kimberly-Clark Worldwide, Inc. | Dosage form cap for an applicator |
| AU2006323048B2 (en) | 2005-11-22 | 2013-07-04 | Nalpropion Pharmaceuticals Llc | Compositions and methods for increasing insulin sensitivity |
| WO2007089318A2 (en) * | 2005-11-23 | 2007-08-09 | Orexigen Therapeutics, Inc. | Compositions and methods for reducing food cravings |
| US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
| US7560489B2 (en) * | 2006-10-11 | 2009-07-14 | Nexmed Holdings, Inc. | Stabilized prostaglandin E composition |
| KR20090075864A (ko) | 2006-10-26 | 2009-07-09 | 오노 야꾸힝 고교 가부시키가이샤 | 첨부제 |
| CA2668884C (en) * | 2006-11-09 | 2016-11-01 | Orexigen Therapeutics, Inc. | Layered pharmaceutical formulations |
| CA2668885C (en) | 2006-11-09 | 2016-08-02 | Orexigen Therapeutics, Inc. | Methods for administering weight loss medications |
| JP2011521973A (ja) | 2008-05-30 | 2011-07-28 | オレキシジェン・セラピューティクス・インコーポレーテッド | 内臓脂肪の状態を処置するための方法 |
| AU2011203867B2 (en) | 2010-01-11 | 2015-12-03 | Nalpropion Pharmaceuticals Llc | Methods of providing weight loss therapy in patients with major depression |
| US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
| EP2858640B1 (en) | 2012-06-06 | 2020-03-25 | Nalpropion Pharmaceuticals LLC | Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk |
| WO2014116770A1 (en) | 2013-01-23 | 2014-07-31 | Arx, Llc | Production of unit dose constructs |
| CN109310646A (zh) | 2016-05-05 | 2019-02-05 | 阿奎斯蒂弗医疗股份有限公司 | 增强递送的肾上腺素组合物 |
| US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3926188A (en) * | 1974-11-14 | 1975-12-16 | Alza Corp | Laminated drug dispenser |
| US4180558A (en) * | 1978-08-21 | 1979-12-25 | Hoffmann-La Roche Inc. | Unit dosage forms |
| US4317447A (en) * | 1979-07-19 | 1982-03-02 | Ortho Pharmaceutical Corporation | Drug delivery system |
| JPS5911563B2 (ja) * | 1980-02-27 | 1984-03-16 | 日本原子力研究所 | 多層構造の徐放性複合体を製造する方法 |
| JPS5770816A (en) * | 1980-10-17 | 1982-05-01 | Ono Pharmaceut Co Ltd | Multilayered film preparation of prostagladin of prolonged action |
| US4335097A (en) * | 1981-01-15 | 1982-06-15 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. | Stabilized, prostaglandin-containing tablets with controlled rate of solubility, for local use and process for the preparation thereof |
| US4451260A (en) * | 1982-03-26 | 1984-05-29 | Minnesota Mining And Manufacturing Company | Sustained release oral medicinal delivery device |
-
1982
- 1982-02-05 JP JP57016331A patent/JPS58134019A/ja active Granted
-
1983
- 1983-02-04 EP EP83300564A patent/EP0086093B1/en not_active Expired
- 1983-02-04 DE DE8383300564T patent/DE3363321D1/de not_active Expired
- 1983-02-04 AT AT83300564T patent/ATE19589T1/de active
- 1983-02-07 US US06/464,174 patent/US4483846A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58134019A (ja) | 1983-08-10 |
| ATE19589T1 (de) | 1986-05-15 |
| EP0086093B1 (en) | 1986-05-07 |
| EP0086093A1 (en) | 1983-08-17 |
| US4483846A (en) | 1984-11-20 |
| DE3363321D1 (en) | 1986-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6365048B2 (US06262066-20010717-C00315.png) | ||
| JPS6366806B2 (US06262066-20010717-C00315.png) | ||
| CA1257167A (en) | Dispensing device with drug delivery patterns | |
| ES2325046T3 (es) | Formulacion farmaceutica extruible por fusion en caliente. | |
| JP2701977B2 (ja) | 疎水性媒体を含有する投薬体 | |
| JP3973684B2 (ja) | 口腔の苦痛状態を治療するための経口投与および方法 | |
| JP3496961B2 (ja) | 有効成分を徐放するための多層マトリックス系 | |
| US7332230B1 (en) | Multilayer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients | |
| US5368861A (en) | Gastric preparation with sustained release | |
| JP2001503054A (ja) | 可溶形態浸透用量送達システム | |
| JPS61246120A (ja) | 浮遊、持続放出性治療用組成物 | |
| NL8401470A (nl) | Osmotische inrichting met tweevoudige thermodynamische activiteit. | |
| JPS61103820A (ja) | 結腸一治療系 | |
| JPH0641406B2 (ja) | 薬剤の送り出し装置 | |
| PT711146E (pt) | Dispositivos osmoticos com revestimentos permeaveis ao vapor | |
| JP2011144193A (ja) | 薬理学的活性物質またはその他の物質の二相放出用薄膜製剤 | |
| RU2316313C2 (ru) | Высвобождающие действующее вещество распадающиеся пленочные препараты и способы их получения | |
| CN104857515B (zh) | 一种控释给药的药芯组合物以及包含该药芯组合物的渗透泵制剂 | |
| JP4653488B2 (ja) | 多層経粘膜的治療システム | |
| JPH06298647A (ja) | 作用物質の放出が調節された、フルピルチン又はその生理学的に認容性の塩を含有する医薬製剤及びその製法 | |
| JPH0137367B2 (US06262066-20010717-C00315.png) | ||
| KR102291180B1 (ko) | 구강내 속붕해 필름형 제제 및 이의 제조방법 | |
| JP2008515944A (ja) | 歯用自己粘着フィルム | |
| JPH0457645B2 (US06262066-20010717-C00315.png) | ||
| JP3645565B2 (ja) | 内圧を制御する手段を含む送出系 |
